In human glioma cells Wachsberger et al. combined the PI3K inhibitor Buparlisib (BKM120) with the HSP90 inhibitor HSP990, which resulted in downregulation of the AKT pathway and induction of apoptosis. This evidence concerns the gene AKT1 and central nervous system cancer.